SHANNON O'MEARA: Open Payments
NPI 1386959716 · DELMAR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 10 payments from 5 companies in 2025. Trend: 2023 $43 · 2024 $0 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $96 |
| ABBVIE INC. | 2 | $41 |
| Lilly USA, LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Organon LLC | 1 | $5 |
Products named: TRELEGY ELLIPTA, SHINGRIX, LINZESS, ZEPBOUND, Rybelsus, AREXVY, UBRELVY, NEXPLANON.
Industry payments across NY — which companies pay providers there.
